CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: all-trans-retinol
Accession: CHEBI:17336
browse the term
Definition: A retinol in which all four exocyclic double bonds have E- (trans-) geometry.
Synonyms: related_synonym: (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; (all-E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; Alphalin; Aquasol A; Chocola A; Formula=C20H30O; InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+; InChIKey=FPIPGXGPPPQFEQ-OVSJKPMPSA-N; Retinol; SMILES=C\\C(=C/CO)\\C=C\\C=C(/C)\\C=C\\C1=C(C)CCCC1(C)C; Vitamin A; Vitamin A1; all-trans-retinyl alcohol; all-trans-vitamin A; all-trans-vitamin A alcohol; retinol (vit A); retinolum; trans-retinol; vitamin A alcohol; vitamin A1 alcohol
alt_id: CHEBI:12783; CHEBI:22349; CHEBI:8816
xref: Beilstein:403040; CAS:11103-57-4; CAS:68-26-8; Chemspider:393012; DrugBank:DB00162; Drug_Central:2831; Gmelin:247497; HMDB:HMDB0000305; KEGG:C00473; KEGG:C17276; KEGG:D00069; KEGG:D06543; KNApSAcK:C00031437; LIPID_MAPS_instance:LMPR01090001
xref_mesh: MESH:D014801
xref: MetaCyc:CPD-13524; PDBeChem:RTL; PMID:10637381; PMID:12074187; PMID:12221269; PMID:12229281; PMID:12548314; PMID:12600856; PMID:1414975; PMID:15041701; PMID:15051608; PMID:15531678; PMID:15622799; PMID:15929633; PMID:16469975; PMID:16507353; PMID:16825693; PMID:17790232; PMID:19264891; PMID:20697621; PMID:2217163; PMID:22444309; PMID:2295828; PMID:25478840; PMID:30510477; PMID:31484771; PMID:7971717; PMID:8464067; PMID:8496140; PMID:9155646; PMID:9736606; Wikipedia:Retinol
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions decreases expression
EXP
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in decreased expression of ABCB1 mRNA]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in decreased expression of ABCB1A mRNA]; Mannitol inhibits the reaction [Vitamin A results in decreased expression of ABCB1 mRNA]; Mannitol inhibits the reaction [Vitamin A results in decreased expression of ABCB1A mRNA] Vitamin A results in decreased expression of ABCB1 mRNA; Vitamin A results in decreased expression of ABCB1A mRNA
CTD
PMID:15327746
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Ace2
angiotensin converting enzyme 2
increases expression
ISO
Vitamin A results in increased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
EXP
Vitamin A deficiency results in decreased expression of ACSS2 mRNA
CTD
PMID:12163651
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
Vitamin A inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]
CTD
PMID:16256175
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Actb
actin, beta
decreases expression
EXP
Vitamin A deficiency results in decreased expression of ACTB mRNA
CTD
PMID:12163651
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actg2
actin gamma 2, smooth muscle
decreases expression multiple interactions
EXP
Vitamin A results in decreased expression of ACTG2 protein Vitamin A results in decreased expression of [Ethanol results in increased expression of ACTG2 protein]
CTD
PMID:16043492
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
G
Afp
alpha-fetoprotein
increases expression
EXP
Vitamin A deficiency results in increased expression of AFP mRNA
CTD
PMID:7519440
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Ager
advanced glycosylation end product-specific receptor
multiple interactions increases expression
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased expression of AGER protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased expression of AGER protein]; [Vitamin A results in increased abundance of Reactive Oxygen Species] which results in increased expression of AGER protein; SB 203580 inhibits the reaction [Vitamin A results in increased expression of AGER protein]
CTD
PMID:18396385 PMID:21807062 PMID:22274401
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
Vitamin A inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA]
CTD
PMID:15728703
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akr1b1
aldo-keto reductase family 1 member B1
decreases response to substance
ISO
AKR1B1 protein results in decreased susceptibility to Vitamin A; AKR1B1 protein results in decreased susceptibility to Vitamin A metabolite
CTD
PMID:19014918
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
decreases response to substance
ISO
AKR1B10 protein results in decreased susceptibility to Vitamin A; AKR1B10 protein results in decreased susceptibility to Vitamin A metabolite
CTD
PMID:19014918
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akt1
AKT serine/threonine kinase 1
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased phosphorylation of AKT1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of AKT1 protein]
CTD
PMID:21807062
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
affects binding
ISO
Vitamin A binds to ALB protein
CTD
PMID:17184834
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
Vitamin A results in decreased expression of ALDH1A2 mRNA
CTD
PMID:30944279
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aox1
aldehyde oxidase 1
multiple interactions
ISO
[Tetrachlorodibenzodioxin co-treated with Vitamin A] results in increased activity of AOX1 protein; [Tetrachlorodibenzodioxin co-treated with Vitamin A] results in increased expression of AOX1 mRNA; Vitamin A inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AOX1 protein]; Vitamin A inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AOX1 mRNA]
CTD
PMID:16292751
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Apod
apolipoprotein D
affects binding
ISO
Vitamin A binds to APOD protein
CTD
PMID:16461020
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
App
amyloid beta precursor protein
multiple interactions increases expression affects expression
EXP
Tretinoin inhibits the reaction [Vitamin A affects the expression of APP mRNA] Vitamin A results in increased expression of APP protein
CTD
PMID:16530976 PMID:22274401
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Ascl1
achaete-scute family bHLH transcription factor 1
increases expression
EXP
Vitamin A deficiency results in increased expression of ASCL1 mRNA
CTD
PMID:12555267
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
G
Bace1
beta-secretase 1
multiple interactions affects expression
EXP
Tretinoin inhibits the reaction [Vitamin A affects the expression of BACE mRNA]
CTD
PMID:16530976
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
Vitamin A results in increased expression of BAX protein
CTD
PMID:16216918
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
EXP
Vitamin A results in decreased expression of BCL2 protein
CTD
PMID:16216918
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmp4
bone morphogenetic protein 4
affects expression
ISO
Vitamin A affects the expression of BMP4 mRNA
CTD
PMID:16120438
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Vitamin A results in increased expression of BTG2 mRNA
CTD
PMID:17234770
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Cab39
calcium binding protein 39
decreases expression
EXP
Vitamin A deficiency results in decreased expression of CAB39 mRNA
CTD
PMID:12163651
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
G
Casp3
caspase 3
multiple interactions decreases activity increases activity
ISO
alpha-Tocopherol inhibits the reaction [Vitamin A results in increased activity of CASP3 protein] Vitamin A results in decreased activity of CASP3 protein
CTD
PMID:16531423 PMID:17618090
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
affects activity decreases activity increases expression multiple interactions decreases expression
ISO EXP
Vitamin A affects the activity of CAT protein Vitamin A results in decreased activity of CAT protein Vitamin A results in increased expression of CAT protein 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased expression of CAT protein]; [Vitamin A results in decreased activity of CAT protein] which results in increased abundance of Hydrogen Peroxide; Vitamin A results in increased expression of and results in increased activity of CAT protein Vitamin A deficiency results in decreased expression of CAT protein; Vitamin A results in decreased expression of CAT protein
CTD
PMID:8602878 PMID:16036340 PMID:17673185 PMID:17727954 PMID:18440196 PMID:18533141 PMID:19842843 PMID:22274401 More...
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
decreases expression increases expression affects expression
ISO EXP
Vitamin A results in decreased expression of CCL2 protein Vitamin A results in increased expression of CCL2 mRNA Vitamin A affects the expression of CCL2 protein
CTD
PMID:16988133 PMID:25051504
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccnd1
cyclin D1
decreases expression
ISO
Vitamin A results in decreased expression of CCND1 mRNA
CTD
PMID:17219422 PMID:17234770
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
decreases expression
EXP
Vitamin A deficiency results in decreased expression of CCND2 mRNA
CTD
PMID:12163651
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Cd14
CD14 molecule
increases expression
ISO
Vitamin A results in increased expression of CD14 mRNA
CTD
PMID:17033190
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd44
CD44 molecule
increases expression
ISO
Vitamin A results in increased expression of CD44 protein
CTD
PMID:16724877
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdh1
cadherin 1
affects expression
ISO
Vitamin A affects the expression of CDH1 mRNA
CTD
PMID:17034753
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Col1a1
collagen type I alpha 1 chain
increases expression multiple interactions
ISO
Vitamin A results in increased expression of COL1A1 mRNA [Cryptoxanthins co-treated with Vitamin A] results in increased expression of COL1A1 mRNA
CTD
PMID:15962303 PMID:17034753
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col2a1
collagen type II alpha 1 chain
multiple interactions
ISO
[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA]
CTD
PMID:16397886
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Col4a2
collagen type IV alpha 2 chain
increases expression
ISO
Vitamin A results in increased expression of COL4A2 mRNA
CTD
PMID:17034753
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Crabp2
cellular retinoic acid binding protein 2
multiple interactions increases expression
ISO
CRABP2 protein promotes the reaction [Vitamin A results in increased expression of TOB1 mRNA] Vitamin A results in increased expression of CRABP2 mRNA
CTD
PMID:16793012 PMID:17034753 PMID:17234770
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Creb1
cAMP responsive element binding protein 1
increases phosphorylation multiple interactions
ISO EXP
Vitamin A results in increased phosphorylation of CREB1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased phosphorylation of CREB1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of CREB1 protein]; AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of CREB1 protein]
CTD
PMID:16280361 PMID:16510265
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Ctnnb1
catenin beta 1
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein]; MG 262 inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein]; Vitamin A results in increased ubiquitination of and results in increased degradation of CTNNB1 protein
CTD
PMID:17219422
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cycs
cytochrome c, somatic
affects localization
EXP
Vitamin A affects the localization of CYCS protein
CTD
PMID:16202537
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
Vitamin A inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Vitamin A inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:15728703
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases oxidation decreases activity
ISO
CYP1B1 protein results in increased oxidation of Vitamin A Vitamin A results in decreased activity of CYP1B1 protein
CTD
PMID:15258110 PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
multiple interactions increases expression affects metabolic processing
ISO EXP
[Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA Vitamin A results in increased expression of CYP26A1 mRNA [R 115866 co-treated with Vitamin A] results in increased expression of CYP26A1 mRNA CYP26A1 protein affects the metabolism of Vitamin A
CTD
PMID:10557354 PMID:16194896 PMID:17244623 PMID:17510468 PMID:22542753 PMID:30944279 More...
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
multiple interactions
EXP
[R 115866 co-treated with Vitamin A] results in increased expression of CYP26B1 mRNA
CTD
PMID:17510468
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
EXP
GH1 protein promotes the reaction [Vitamin A affects the expression of and affects the activity of CYP2C11 protein]; Vitamin A affects the expression of and affects the activity of CYP2C11 protein
CTD
PMID:15963505
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Dcp2
decapping mRNA 2
decreases expression
EXP
Vitamin A deficiency results in decreased expression of DCP2 mRNA
CTD
PMID:12163651
NCBI chr18:36,750,732...36,787,067
Ensembl chr18:36,750,732...36,788,557
G
Dgat1
diacylglycerol O-acyltransferase 1
multiple interactions
ISO
DGAT1 protein results in increased metabolism of [Palmitoyl Coenzyme A co-treated with Vitamin A]
CTD
PMID:16214399
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dhh
desert hedgehog signaling molecule
multiple interactions
EXP
Vitamin A inhibits the reaction [Valproic Acid results in increased expression of DHH mRNA]
CTD
PMID:35594946
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
G
Dhrs3
dehydrogenase/reductase 3
decreases abundance
ISO
DHRS3 gene mutant form results in decreased abundance of Vitamin A
CTD
PMID:24005908
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs9
dehydrogenase/reductase 9
increases metabolic processing
ISO
DHRS9 protein results in increased metabolism of Vitamin A
CTD
PMID:11304534
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
G
Drd2
dopamine receptor D2
decreases expression
EXP
Vitamin A results in decreased expression of DRD2 protein
CTD
PMID:22274401
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
decreases expression
EXP
Vitamin A deficiency results in decreased expression of EEF1A1 mRNA
CTD
PMID:12163651
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
G
Egfr
epidermal growth factor receptor
increases expression
EXP
Vitamin A deficiency results in increased expression of EGFR mRNA
CTD
PMID:7519440
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif4a2
eukaryotic translation initiation factor 4A2
decreases expression
EXP
Vitamin A deficiency results in decreased expression of EIF4A2 mRNA
CTD
PMID:12163651
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
G
Epo
erythropoietin
increases expression multiple interactions
ISO EXP
Vitamin A results in increased expression of EPO protein Vitamin A inhibits the reaction [Hydrogen Peroxide results in decreased expression of EPO protein]
CTD
PMID:9927288 PMID:16960172
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Esr1
estrogen receptor 1
multiple interactions
ISO
Vitamin A inhibits the reaction [Paclitaxel results in increased expression of ESR1 mRNA]
CTD
PMID:19340624
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fas
Fas cell surface death receptor
decreases expression
ISO
Vitamin A results in decreased expression of FAS mRNA
CTD
PMID:17034753
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fn1
fibronectin 1
decreases secretion
ISO
Vitamin A results in decreased secretion of FN1 protein
CTD
PMID:17225872
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fnta
farnesyltransferase, CAAX box, subunit alpha
multiple interactions
EXP
[Vitamin A co-treated with perillyl alcohol] results in decreased expression of FNTA protein
CTD
PMID:15959631
NCBI chr16:66,065,131...66,083,460
Ensembl chr16:66,065,132...66,083,460
G
Fntb
farnesyltransferase, CAAX box, subunit beta
multiple interactions increases expression
EXP
[perillyl alcohol co-treated with Vitamin A] results in decreased expression of FNTB mRNA Vitamin A results in increased expression of FNTB mRNA; Vitamin A results in increased expression of FNTB protein
CTD
PMID:15959631
NCBI chr 6:95,536,540...95,619,587
Ensembl chr 6:95,470,683...95,619,586
G
Foxa1
forkhead box A1
increases expression
ISO
Vitamin A results in increased expression of FOXA1 mRNA
CTD
PMID:17034753
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
G
Foxa2
forkhead box A2
multiple interactions
EXP
Vitamin A inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein]
CTD
PMID:16863852
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Fth1
ferritin heavy chain 1
multiple interactions decreases expression
EXP
Iron deficiency promotes the reaction [Vitamin A deficiency results in decreased expression of FTH1 protein] Vitamin A deficiency results in decreased expression of FTH1 mRNA; Vitamin A deficiency results in decreased expression of FTH1 protein
CTD
PMID:22154532
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
increases expression
ISO
Vitamin A results in increased expression of GABRB3 mRNA
CTD
PMID:17225872
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
G
Gata6
GATA binding protein 6
increases expression
ISO
Vitamin A results in increased expression of GATA6 mRNA
CTD
PMID:17034753
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Gcg
glucagon
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of GCG mRNA
CTD
PMID:17244017
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Gh1
growth hormone 1
multiple interactions
EXP
GH1 protein promotes the reaction [Vitamin A affects the expression of and affects the activity of CYP2C11 protein]
CTD
PMID:15963505
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Gja1
gap junction protein, alpha 1
multiple interactions increases expression
EXP
Vitamin A inhibits the reaction [nitrofen results in increased expression of GJA1 mRNA] Vitamin A results in increased expression of GJA1 mRNA
CTD
PMID:12031251 PMID:16292552
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gnai1
G protein subunit alpha i1
increases expression
EXP
Vitamin A results in increased expression of GNAI1 protein
CTD
PMID:16757122
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnai2
G protein subunit alpha i2
increases expression
EXP
Vitamin A results in increased expression of GNAI2 protein
CTD
PMID:16757122
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gpt
glutamic--pyruvic transaminase
increases activity multiple interactions
EXP
Vitamin A results in increased activity of GPT protein gadolinium chloride inhibits the reaction [Vitamin A results in increased activity of GPT protein]
CTD
PMID:8627517
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
[Vitamin A co-treated with Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 protein
CTD
PMID:17179735
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Grhl3
grainyhead-like transcription factor 3
increases response to substance
ISO
GRHL3 gene mutant form results in increased susceptibility to Vitamin A
CTD
PMID:6635991
NCBI chr 5:147,774,161...147,806,291
Ensembl chr 5:147,774,160...147,806,160
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Vitamin A inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
H3f4
H3.4 histone, cluster member
multiple interactions increases acetylation
ISO
Vitamin A affects the reaction [H3F4 protein modified form binds to PCK1 promoter] Vitamin A results in increased acetylation of H3F4 protein
CTD
PMID:16317119
NCBI chr10:43,740,702...43,741,262
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
Vitamin A results in increased expression of HBEGF mRNA
CTD
PMID:19648781
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hoxa1
homeobox A1
multiple interactions increases expression
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased expression of HOXA1]; 3,4-methylenedioxy-beta-nitrostyrene inhibits the reaction [Vitamin A results in increased expression of HOXA1]; 4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; BAY 11-7085 inhibits the reaction [Vitamin A results in increased expression of HOXA1]; bisphenol A inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Camptothecin inhibits the reaction [Vitamin A results in increased expression of HOXA1]; citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; di-n-pentyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Diethylstilbestrol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Disulfiram inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Genistein inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; N,N'-bis(dichloroacetyl)-1,8-octamethylenediamine inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; nitrofen inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] Vitamin A results in increased expression of HOXA1; Vitamin A results in increased expression of HOXA1 mRNA
CTD
PMID:23696197 PMID:26820057
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
G
Hoxa3
homeobox A3
affects expression
ISO
Vitamin A affects the expression of HOXA3 mRNA
CTD
PMID:10992263
NCBI chr 4:81,269,243...81,313,218
Ensembl chr 4:81,269,243...81,313,218
G
Ifng
interferon gamma
decreases expression affects expression
ISO EXP
Vitamin A results in decreased expression of IFNG protein Vitamin A affects the expression of IFNG protein
CTD
PMID:14624943 PMID:17289162
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
increases expression
EXP
Vitamin A results in increased expression of IL1B protein
CTD
PMID:25051504
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
increases expression
ISO
Vitamin A results in increased expression of IL2 mRNA
CTD
PMID:15506942
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
decreases expression
ISO
Vitamin A results in decreased expression of IL4 protein
CTD
PMID:14624943
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Inhba
inhibin subunit beta A
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in decreased expression of SHH mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of GCG mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of INS1 mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of INS2 mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of PDX1 mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of PPY mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of PTF1A mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of SOX17 mRNA; [Vitamin A co-treated with INHBA protein] results in increased expression of SST mRNA
CTD
PMID:17244017
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Ins1
insulin 1
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of INS1 mRNA
CTD
PMID:17244017
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of INS2 mRNA
CTD
PMID:17244017
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Ireb2
iron responsive element binding protein 2
increases expression
EXP
Vitamin A deficiency results in increased expression of IREB2 mRNA
CTD
PMID:22154532
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
G
Itga3
integrin subunit alpha 3
increases expression
ISO
Vitamin A results in increased expression of ITGA3 protein
CTD
PMID:17241391
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itgb1
integrin subunit beta 1
affects localization increases expression
ISO
Vitamin A affects the localization of ITGB1 protein Vitamin A results in increased expression of ITGB1 protein
CTD
PMID:17241391
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Ivl
involucrin
increases expression
ISO
Vitamin A results in increased expression of IVL mRNA
CTD
PMID:17034753
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Jak2
Janus kinase 2
affects localization
EXP
Vitamin A affects the localization of JAK2 protein
CTD
PMID:15963505
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Krt18
keratin 18
increases expression
ISO
Vitamin A results in increased expression of KRT18 mRNA
CTD
PMID:17034753
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt19
keratin 19
increases expression decreases expression
ISO EXP
Vitamin A results in increased expression of KRT19 mRNA Vitamin A deficiency results in decreased expression of KRT19 mRNA
CTD
PMID:12163651 PMID:17034753
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt7
keratin 7
increases expression
ISO
Vitamin A results in increased expression of KRT7 mRNA
CTD
PMID:17034753
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt8
keratin 8
increases expression
ISO
Vitamin A results in increased expression of KRT8 mRNA
CTD
PMID:17034753
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Lep
leptin
multiple interactions
EXP
LEP gene mutant form promotes the reaction [Vitamin A results in increased expression of UCP1 mRNA]
CTD
PMID:16493122
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lrat
lecithin retinol acyltransferase
multiple interactions decreases expression affects expression increases expression
ISO EXP
[STRA6 protein co-treated with LRAT protein] results in increased uptake of Vitamin A Vitamin A results in decreased expression of LRAT mRNA Vitamin A affects the expression of LRAT mRNA Vitamin A results in increased expression of LRAT mRNA [Vitamin A co-treated with Tetrachlorodibenzodioxin] results in increased expression of LRAT mRNA; Tetrachlorodibenzodioxin inhibits the reaction [Vitamin A results in increased expression of LRAT mRNA]
CTD
PMID:12576510 PMID:16292751 PMID:18316031 PMID:30944279
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Lrp2
LDL receptor related protein 2
multiple interactions
ISO
LRP2 protein results in increased uptake of and affects the abundance of Vitamin A
CTD
PMID:16251603
NCBI chr 3:54,189,305...54,346,769
Ensembl chr 3:54,189,308...54,346,708
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions increases phosphorylation
EXP
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein]; AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein]; Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein]
CTD
PMID:16510265
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Map2k2
mitogen activated protein kinase kinase 2
multiple interactions increases phosphorylation
EXP
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K2 protein]; AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K2 protein]; Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K2 protein]
CTD
PMID:16510265
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein]; AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK1 protein]; Vitamin A results in decreased phosphorylation of and results in decreased activity of MAPK1 protein
CTD
PMID:16043492 PMID:16510265
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK3 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK3 protein]; AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAPK3 protein]; Vitamin A results in decreased phosphorylation of and results in decreased activity of MAPK3 protein
CTD
PMID:16043492 PMID:16510265
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mbl2
mannose binding lectin 2
multiple interactions
ISO
MBL2 gene polymorphism affects the susceptibility to [Vitamin A co-treated with beta Carotene]
CTD
PMID:16960176
NCBI chr 1:228,016,439...228,024,736
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
affects expression
ISO
Vitamin A affects the expression of MCL1 mRNA
CTD
PMID:17034753
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Meis1
Meis homeobox 1
increases expression multiple interactions
ISO
Vitamin A results in increased expression of MEIS1 mRNA [RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA]
CTD
PMID:16397886 PMID:17034753
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
G
Meis2
Meis homeobox 2
increases expression multiple interactions
ISO
Vitamin A results in increased expression of MEIS2 mRNA [RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA]
CTD
PMID:16397886 PMID:17034753
NCBI chr 3:102,742,904...102,944,833
Ensembl chr 3:102,742,900...102,949,696
G
Meox1
mesenchyme homeobox 1
increases expression
ISO
Vitamin A results in increased expression of MEOX1 mRNA
CTD
PMID:17034753
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
decreases expression
EXP
Vitamin A deficiency results in decreased expression of COX3 mRNA
CTD
PMID:12163651
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
increases expression
ISO
Vitamin A results in increased expression of MUC5AC mRNA
CTD
PMID:17034753
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
Vitamin A results in decreased expression of MYC mRNA
CTD
PMID:17219422
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncoa1
nuclear receptor coactivator 1
multiple interactions
ISO
Vitamin A affects the reaction [NCOA1 protein binds to PCK1 promoter]
CTD
PMID:16317119
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
G
Neurog3
neurogenin 3
decreases expression
ISO
Vitamin A results in decreased expression of NEUROG3 mRNA
CTD
PMID:30944279
NCBI chr20:30,079,780...30,081,262
Ensembl chr20:30,079,780...30,081,262
G
Nkx2-1
NK2 homeobox 1
multiple interactions
ISO EXP
Vitamin A inhibits the reaction [nitrofen results in decreased expression of NKX2-1 mRNA] Vitamin A inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein]
CTD
PMID:16490937 PMID:16863852
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
G
Nos2
nitric oxide synthase 2
increases expression
EXP
Vitamin A deficiency results in increased expression of NOS2
CTD
PMID:16036340
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
increases expression
EXP
Vitamin A deficiency results in increased expression of NOS3
CTD
PMID:16036340
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Npy1r
neuropeptide Y receptor Y1
increases response to substance
ISO
NPY1R protein results in increased susceptibility to Vitamin A
CTD
PMID:17400914
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
NR1I3 protein affects the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased abundance of Vitamin A]
CTD
PMID:31449830
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrgn
neurogranin
affects expression
EXP
Vitamin A affects the expression of NRGN mRNA
CTD
PMID:14529804
NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516
G
Odc1
ornithine decarboxylase 1
decreases expression
EXP
Vitamin A deficiency results in decreased expression of ODC1 mRNA
CTD
PMID:12163651
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Olr1
oxidized low density lipoprotein receptor 1
increases expression
ISO
Vitamin A results in increased expression of OLR1 mRNA
CTD
PMID:17034753
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Oprm1
opioid receptor, mu 1
affects expression
EXP
Vitamin A affects the expression of OPRM1 mRNA; Vitamin A affects the expression of OPRM1 protein
CTD
PMID:17289162
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Pax3
paired box 3
multiple interactions
EXP
Vitamin A inhibits the reaction [nitrofen results in decreased expression of PAX3 mRNA]
CTD
PMID:16481245
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
G
Pck1
phosphoenolpyruvate carboxykinase 1
affects expression multiple interactions
ISO
Vitamin A affects the expression of PCK1 mRNA [Tretinoin co-treated with Alitretinoin] affects the reaction [Vitamin A affects the expression of PCK1 mRNA]; Vitamin A affects the reaction [H3F4 protein modified form binds to PCK1 promoter]; Vitamin A affects the reaction [NCOA1 protein binds to PCK1 promoter]; Vitamin A affects the reaction [PPARA protein binds to PCK1 promoter]; Vitamin A affects the reaction [PPARGC1A protein binds to PCK1 promoter]
CTD
PMID:16317119 PMID:16713227
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pdx1
pancreatic and duodenal homeobox 1
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of PDX1 mRNA
CTD
PMID:17244017
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
G
Pomc
proopiomelanocortin
increases expression
EXP
Vitamin A results in increased expression of POMC protein
CTD
PMID:17373634
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
Vitamin A affects the reaction [PPARA protein binds to PCK1 promoter]
CTD
PMID:16713227
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
EXP
Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA] Vitamin A results in increased expression of PPARG mRNA
CTD
PMID:15203375 PMID:16180333
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO
Vitamin A affects the reaction [PPARGC1A protein binds to PCK1 promoter]
CTD
PMID:16317119
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppy
pancreatic polypeptide
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of PPY mRNA
CTD
PMID:17244017
NCBI chr10:87,054,747...87,056,044
Ensembl chr10:87,054,756...87,055,455
G
Prm1
protamine 1
decreases expression
ISO
Vitamin A results in decreased expression of PRM1 mRNA
CTD
PMID:30944279
NCBI chr10:4,871,817...4,872,312
G
Ptf1a
pancreas associated transcription factor 1a
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of PTF1A mRNA
CTD
PMID:17244017
NCBI chr17:82,051,281...82,053,135
Ensembl chr17:82,051,281...82,053,135
G
Ptgds
prostaglandin D2 synthase
affects binding
ISO
Vitamin A binds to PTGDS protein
CTD
PMID:16461020
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Vitamin A deficiency results in increased expression of PTGS2
CTD
PMID:16036340
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn6
protein tyrosine phosphatase, non-receptor type 6
multiple interactions
EXP
Vitamin A affects the localization of and affects the phosphorylation of PTPN6 protein
CTD
PMID:15963505
NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984
G
Rara
retinoic acid receptor, alpha
multiple interactions increases expression
ISO EXP
[Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA [Valproic Acid co-treated with Vitamin A deficiency] affects the expression of RARA protein; [Valproic Acid co-treated with Vitamin A deficiency] affects the reaction [RARA protein binds to RET promoter] Vitamin A results in increased expression of RARA mRNA Vitamin A deficiency results in increased expression of RARA mRNA [RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA; [RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA; [RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA; [RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA]; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA]; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA]; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA]
CTD
PMID:7519440 PMID:16397886 PMID:17034753 PMID:17225872 PMID:17244623 PMID:30944279 PMID:32526256 More...
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rarb
retinoic acid receptor, beta
decreases expression affects expression multiple interactions increases expression
ISO EXP
Vitamin A results in decreased expression of RARB mRNA Vitamin A affects the expression of RARB mRNA Vitamin A deficiency results in decreased expression of RARB mRNA [R 115866 co-treated with Vitamin A] results in increased expression of RARB mRNA; Tretinoin inhibits the reaction [Vitamin A affects the expression of RARB mRNA]; Vitamin A inhibits the reaction [Safflower Oil results in decreased expression of RARB mRNA] Vitamin A results in increased expression of RARB mRNA
CTD
PMID:7519440 PMID:14529804 PMID:15203375 PMID:15754000 PMID:16530976 PMID:17034753 PMID:17510468 PMID:30944279 More...
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rarg
retinoic acid receptor, gamma
multiple interactions
ISO
RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of COL2A1 mRNA]; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA]; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS1 mRNA]; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA]
CTD
PMID:16397886
NCBI chr 7:133,367,833...133,390,301
Ensembl chr 7:133,367,833...133,390,177
G
Rarres1
retinoic acid receptor responder 1
increases expression
ISO
Vitamin A results in increased expression of RARRES1 mRNA
CTD
PMID:17034753
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
G
Rbp1
retinol binding protein 1
increases uptake increases abundance multiple interactions affects expression increases expression
ISO EXP
RBP1 protein results in increased uptake of Vitamin A RBP1 gene mutant form results in increased abundance of Vitamin A [RBP1 gene mutant form results in increased abundance of Vitamin A] which results in increased expression of RBP2 mRNA Vitamin A affects the expression of RBP1 mRNA Vitamin A results in increased expression of RBP1 mRNA
CTD
PMID:12576510 PMID:16150442 PMID:16793012 PMID:21670153
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rbp2
retinol binding protein 2
multiple interactions
ISO
[RBP1 gene mutant form results in increased abundance of Vitamin A] which results in increased expression of RBP2 mRNA
CTD
PMID:21670153
NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473
G
Rbp4
retinol binding protein 4
affects binding multiple interactions increases secretion decreases secretion
ISO
Vitamin A binds to RBP4 protein Vitamin A results in decreased expression of and results in decreased secretion of RBP4 protein Fenretinide analog inhibits the reaction [Vitamin A promotes the reaction [RBP4 protein binds to TTR protein]]; Vitamin A promotes the reaction [RBP4 protein binds to TTR protein]; Vitamin A results in decreased expression of and results in decreased secretion of RBP4 protein Vitamin A results in increased secretion of RBP4 protein Vitamin A deficiency results in decreased secretion of RBP4 protein
CTD
PMID:16461020 PMID:16762690 PMID:18316031 PMID:21591606 PMID:22001960 PMID:22542753 More...
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Rdh10
retinol dehydrogenase 10
increases oxidation
ISO
RDH10 protein results in increased oxidation of Vitamin A
CTD
PMID:17473173
NCBI chr 5:3,186,671...3,215,572
Ensembl chr 5:3,188,445...3,215,572
G
Rdh11
retinol dehydrogenase 11
increases oxidation
ISO
RDH11 protein results in increased oxidation of Vitamin A
CTD
PMID:16968212
NCBI chr 6:97,979,377...97,995,252
Ensembl chr 6:97,979,378...97,995,252
G
Rdh12
retinol dehydrogenase 12
increases chemical synthesis
ISO
RDH12 protein results in increased chemical synthesis of Vitamin A
CTD
PMID:16269441
NCBI chr 6:98,015,465...98,028,388
Ensembl chr 6:98,015,465...98,028,388
G
Rdh5
retinol dehydrogenase 5
increases oxidation
ISO
RDH5 protein results in increased oxidation of Vitamin A
CTD
PMID:16968212
NCBI chr 7:1,341,172...1,346,863
Ensembl chr 7:1,340,934...1,351,558
G
Ret
ret proto-oncogene
multiple interactions
EXP
[Valproic Acid co-treated with Vitamin A deficiency] affects the expression of RET protein; [Valproic Acid co-treated with Vitamin A deficiency] affects the reaction [RARA protein binds to RET promoter]
CTD
PMID:32526256
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Retn
resistin
decreases expression
ISO
Vitamin A results in decreased expression of RETN mRNA
CTD
PMID:15047602
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
G
Rhoa
ras homolog family member A
multiple interactions increases expression
EXP
[perillyl alcohol co-treated with Vitamin A] results in increased expression of RHOA mRNA Vitamin A results in increased expression of RHOA mRNA
CTD
PMID:15959631
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rhob
ras homolog family member B
multiple interactions increases expression
EXP
[perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB mRNA; [perillyl alcohol co-treated with Vitamin A] affects the expression of RHOB protein Vitamin A results in increased expression of RHOB mRNA; Vitamin A results in increased expression of RHOB protein
CTD
PMID:15959631
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Rora
RAR-related orphan receptor A
multiple interactions
EXP
Vitamin A deficiency promotes the reaction [Valproic Acid results in decreased expression of RORA protein]
CTD
PMID:33991534
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpe65
retinoid isomerohydrolase RPE65
increases chemical synthesis increases metabolic processing
ISO
RPE65 protein results in increased chemical synthesis of Vitamin A RPE65 protein results in increased metabolism of Vitamin A
CTD
PMID:16150724 PMID:16828753
NCBI chr 2:248,766,497...248,798,403
Ensembl chr 2:248,766,612...248,798,403
G
Runx2
RUNX family transcription factor 2
multiple interactions
ISO
[Cryptoxanthins co-treated with Vitamin A] results in increased expression of RUNX2 mRNA
CTD
PMID:15962303
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Rxra
retinoid X receptor alpha
multiple interactions increases expression
ISO EXP
[Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA Vitamin A results in increased expression of RXRA mRNA Vitamin A results in increased expression of RXRA protein
CTD
PMID:16180333 PMID:17219422 PMID:17244623
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Rxrb
retinoid X receptor beta
affects expression
EXP
Vitamin A affects the expression of RXRB mRNA
CTD
PMID:14529804
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
G
Rxrg
retinoid X receptor gamma
affects expression decreases expression increases expression
EXP ISO
Vitamin A affects the expression of RXRG mRNA Vitamin A results in decreased expression of RXRG mRNA Vitamin A results in increased expression of RXRG protein
CTD
PMID:14529804 PMID:17219422 PMID:30944279
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Sdr16c5
short chain dehydrogenase/reductase family 16C, member 5
increases oxidation increases metabolic processing
ISO
SDR16C5 protein results in increased oxidation of Vitamin A SDR16C5 protein results in increased metabolism of Vitamin A
CTD
PMID:18926804 PMID:27793605
NCBI chr 5:17,018,813...17,043,974
Ensembl chr 5:17,018,813...17,040,970
G
Sftpb
surfactant protein B
multiple interactions
EXP ISO
Vitamin A inhibits the reaction [nitrofen results in decreased expression of SFTPB mRNA]; Vitamin A inhibits the reaction [nitrofen results in decreased expression of SFTPB protein]
CTD
PMID:11588001 PMID:16490937 PMID:16863852
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
multiple interactions decreases expression
EXP
Vitamin A inhibits the reaction [nitrofen results in decreased expression of SFTPC mRNA] Vitamin A results in decreased expression of SFTPC protein
CTD
PMID:11588001
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Shh
sonic hedgehog signaling molecule
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in decreased expression of SHH mRNA
CTD
PMID:17244017
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Slc1a2
solute carrier family 1 member 2
multiple interactions increases expression
ISO
Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein] Vitamin A results in increased expression of SLC1A2 protein
CTD
PMID:17138558
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc30a1
solute carrier family 30 member 1
decreases expression
EXP
Vitamin A deficiency results in decreased expression of SLC30A1 protein
CTD
PMID:12421840
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
G
Slc30a2
solute carrier family 30 member 2
multiple interactions
EXP
[Zinc deficiency co-treated with Vitamin A deficiency] results in increased expression of SLC30A2 mRNA
CTD
PMID:12421840
NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956
G
Slc30a4
solute carrier family 30 member 4
increases expression
EXP
Vitamin A deficiency results in increased expression of SLC30A4 mRNA; Vitamin A deficiency results in increased expression of SLC30A4 protein
CTD
PMID:12421840
NCBI chr 3:109,753,270...109,775,306
Ensembl chr 3:109,753,273...109,775,306
G
Snca
synuclein alpha
increases expression
EXP
Vitamin A results in increased expression of SNCA protein
CTD
PMID:22274401
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Sncb
synuclein, beta
decreases expression
EXP
Vitamin A results in decreased expression of SNCB protein
CTD
PMID:22274401
NCBI chr17:9,846,802...9,855,013
Ensembl chr17:9,846,802...9,855,012
G
Sod1
superoxide dismutase 1
increases activity
EXP
Vitamin A results in increased activity of SOD1 protein
CTD
PMID:22274401
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases activity
EXP
Vitamin A results in increased activity of SOD2 protein
CTD
PMID:22274401
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox17
SRY-box transcription factor 17
multiple interactions
ISO
[Vitamin A co-treated with INHBA protein] results in increased expression of SOX17 mRNA
CTD
PMID:17244017
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
G
Sox9
SRY-box transcription factor 9
multiple interactions
ISO
[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA]
CTD
PMID:16397886
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions increases phosphorylation
EXP
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of SRC protein]; Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of SRC protein]
CTD
PMID:16510265
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Sst
somatostatin
multiple interactions affects expression
ISO EXP
[Vitamin A co-treated with INHBA protein] results in increased expression of SST mRNA Vitamin A affects the expression of SST protein
CTD
PMID:16757122 PMID:17244017
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
G
Stat3
signal transducer and activator of transcription 3
affects expression
EXP
Vitamin A affects the expression of STAT3 protein
CTD
PMID:15963505
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
multiple interactions
EXP
Vitamin A affects the phosphorylation of and affects the localization of STAT5A protein
CTD
PMID:15963505
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stra6
signaling receptor and transporter of retinol STRA6
multiple interactions increases transport
ISO
[STRA6 protein co-treated with LRAT protein] results in increased uptake of Vitamin A STRA6 protein results in increased transport of Vitamin A
CTD
PMID:18316031
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
G
Stra8
stimulated by retinoic acid 8
increases expression
ISO
Vitamin A results in increased expression of STRA8 mRNA
CTD
PMID:16461896
NCBI chr 4:63,601,443...63,624,777
Ensembl chr 4:63,601,604...63,624,771
G
Sycp3
synaptonemal complex protein 3
decreases expression
ISO
Vitamin A results in decreased expression of SYCP3 mRNA
CTD
PMID:30944279
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
G
Tfrc
transferrin receptor
decreases expression increases expression
ISO EXP
Vitamin A results in decreased expression of TFRC protein Vitamin A deficiency results in increased expression of TFRC mRNA; Vitamin A deficiency results in increased expression of TFRC protein
CTD
PMID:16960172 PMID:22154532
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfa
transforming growth factor alpha
increases expression
EXP
Vitamin A deficiency results in increased expression of TGFA mRNA
CTD
PMID:7519440
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb3
transforming growth factor, beta 3
increases expression
ISO
Vitamin A results in increased expression of TGFB3 mRNA
CTD
PMID:17225872
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgfbr1
transforming growth factor, beta receptor 1
decreases expression
ISO
Vitamin A results in decreased expression of TGFBR1 mRNA
CTD
PMID:17225872
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
increases expression
ISO
Vitamin A results in increased expression of TGFBR2 mRNA
CTD
PMID:17225872
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Tgm2
transglutaminase 2
increases expression affects expression
ISO EXP
Vitamin A results in increased expression of TGM2 mRNA Vitamin A affects the expression of TGM2 mRNA
CTD
PMID:14529804 PMID:17034753
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Tlr2
toll-like receptor 2
increases expression
ISO
Vitamin A results in increased expression of TLR2 mRNA
CTD
PMID:17033190
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
increases expression
ISO
Vitamin A results in increased expression of TLR4 mRNA
CTD
PMID:17033190
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmem245
transmembrane protein 245
decreases expression
EXP
Vitamin A deficiency results in decreased expression of TMEM245 mRNA
CTD
PMID:12163651
NCBI chr 5:71,570,952...71,647,915
Ensembl chr 5:71,514,858...71,647,763
G
Tnf
tumor necrosis factor
affects secretion increases expression
EXP
Vitamin A affects the secretion of TNF protein Vitamin A results in increased expression of TNF mRNA; Vitamin A results in increased expression of TNF protein
CTD
PMID:15135310 PMID:17289162 PMID:22274401
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tob1
transducer of ErbB-2.1
multiple interactions increases expression
ISO
CRABP2 protein promotes the reaction [Vitamin A results in increased expression of TOB1 mRNA]
CTD
PMID:17234770
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Tpi1
triosephosphate isomerase 1
increases expression
EXP
Vitamin A results in increased expression of TPI1 mRNA alternative form
CTD
PMID:8793052
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Ttr
transthyretin
multiple interactions
ISO
Fenretinide analog inhibits the reaction [Vitamin A promotes the reaction [RBP4 protein binds to TTR protein]]; Vitamin A promotes the reaction [RBP4 protein binds to TTR protein]
CTD
PMID:21591606
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Ubc
ubiquitin C
increases expression
EXP
Vitamin A deficiency results in increased expression of UBC mRNA
CTD
PMID:12163651
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Uchl1
ubiquitin C-terminal hydrolase L1
multiple interactions
EXP
[Valproic Acid co-treated with Vitamin A deficiency] affects the expression of UCHL1 protein
CTD
PMID:32526256
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ucp1
uncoupling protein 1
multiple interactions
EXP
LEP gene mutant form promotes the reaction [Vitamin A results in increased expression of UCP1 mRNA]
CTD
PMID:16493122
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
EXP
Vitamin A inhibits the reaction [Triiodothyronine results in decreased expression of UGT1A1 mRNA]
CTD
PMID:11299074
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions decreases expression
EXP
Vitamin A inhibits the reaction [Triiodothyronine results in increased expression of UGT1A6 mRNA] Vitamin A deficiency results in decreased expression of UGT1A6 mRNA
CTD
PMID:11299074 PMID:12163651
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Cdh1
cadherin 1
affects expression
ISO
4-oxoretinol affects the expression of CDH1 mRNA
CTD
PMID:17034753
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
4-oxoretinol results in increased expression of COL1A1 mRNA
CTD
PMID:17034753
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col4a2
collagen type IV alpha 2 chain
increases expression
ISO
4-oxoretinol results in increased expression of COL4A2 mRNA
CTD
PMID:17034753
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Crabp2
cellular retinoic acid binding protein 2
increases expression
ISO
4-oxoretinol results in increased expression of CRABP2 mRNA
CTD
PMID:17034753
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
affects chemical synthesis
ISO
CYP26A1 protein affects the chemical synthesis of 4-oxoretinol
CTD
PMID:10557354
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Fas
Fas cell surface death receptor
decreases expression
ISO
4-oxoretinol results in decreased expression of FAS mRNA
CTD
PMID:17034753
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Foxa1
forkhead box A1
increases expression
ISO
4-oxoretinol results in increased expression of FOXA1 mRNA
CTD
PMID:17034753
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
G
Gata6
GATA binding protein 6
increases expression
ISO
4-oxoretinol results in increased expression of GATA6 mRNA
CTD
PMID:17034753
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Itgam
integrin subunit alpha M
increases expression
ISO
4-oxoretinol results in increased expression of ITGAM protein
CTD
PMID:9581846
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Ivl
involucrin
increases expression
ISO
4-oxoretinol results in increased expression of IVL mRNA
CTD
PMID:17034753
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Krt18
keratin 18
increases expression
ISO
4-oxoretinol results in increased expression of KRT18 mRNA
CTD
PMID:17034753
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt19
keratin 19
increases expression
ISO
4-oxoretinol results in increased expression of KRT19 mRNA
CTD
PMID:17034753
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt7
keratin 7
increases expression
ISO
4-oxoretinol results in increased expression of KRT7 mRNA
CTD
PMID:17034753
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt8
keratin 8
increases expression
ISO
4-oxoretinol results in increased expression of KRT8 mRNA
CTD
PMID:17034753
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
4-oxoretinol results in decreased expression of MCL1 mRNA
CTD
PMID:17034753
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Meis1
Meis homeobox 1
increases expression
ISO
4-oxoretinol results in increased expression of MEIS1 mRNA
CTD
PMID:17034753
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
G
Meis2
Meis homeobox 2
increases expression
ISO
4-oxoretinol results in increased expression of MEIS2 mRNA
CTD
PMID:17034753
NCBI chr 3:102,742,904...102,944,833
Ensembl chr 3:102,742,900...102,949,696
G
Meox1
mesenchyme homeobox 1
increases expression
ISO
4-oxoretinol results in increased expression of MEOX1 mRNA
CTD
PMID:17034753
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
increases expression
ISO
4-oxoretinol results in increased expression of MUC5AC mRNA
CTD
PMID:17034753
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Olr1
oxidized low density lipoprotein receptor 1
increases expression
ISO
4-oxoretinol results in increased expression of OLR1 mRNA
CTD
PMID:17034753
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Rara
retinoic acid receptor, alpha
increases expression
ISO
4-oxoretinol results in increased expression of RARA mRNA
CTD
PMID:17034753
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rarres1
retinoic acid receptor responder 1
increases expression
ISO
4-oxoretinol results in increased expression of RARRES1 mRNA
CTD
PMID:17034753
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
G
Tgm2
transglutaminase 2
increases expression
ISO
4-oxoretinol results in increased expression of TGM2 mRNA
CTD
PMID:17034753
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Cat
catalase
increases activity
EXP
retinol palmitate results in increased activity of CAT protein
CTD
PMID:20679000
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ep300
E1A binding protein p300
multiple interactions
EXP
retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein]
CTD
PMID:17164434
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Il10
interleukin 10
multiple interactions
ISO
retinol palmitate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:17377406
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
retinol palmitate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1RN protein]
CTD
PMID:17377406
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Lipe
lipase E, hormone sensitive type
increases hydrolysis multiple interactions
ISO
LIPE protein results in increased hydrolysis of retinol palmitate PLIN3 protein inhibits the reaction [LIPE protein results in increased hydrolysis of retinol palmitate]
CTD
PMID:16741517
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
G
Mmp9
matrix metallopeptidase 9
multiple interactions increases expression
EXP
retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein]; retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein] retinol palmitate results in increased expression of MMP9 mRNA
CTD
PMID:17164434
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Plin3
perilipin 3
multiple interactions
ISO
PLIN3 protein inhibits the reaction [LIPE protein results in increased hydrolysis of retinol palmitate]; PLIN3 protein inhibits the reaction [PNPLA4 protein results in increased hydrolysis of retinol palmitate]
CTD
PMID:16741517
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Pnpla4
patatin like phospholipase domain containing 4
increases hydrolysis multiple interactions
ISO
PNPLA4 protein results in increased hydrolysis of retinol palmitate PLIN3 protein inhibits the reaction [PNPLA4 protein results in increased hydrolysis of retinol palmitate]
CTD
PMID:16741517
NCBI chr X:42,313,554...42,318,451
Ensembl chr X:42,305,373...42,318,552
G
Rara
retinoic acid receptor, alpha
multiple interactions
EXP
retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein]
CTD
PMID:17164434
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Scarb1
scavenger receptor class B, member 1
increases expression
EXP
retinol palmitate results in increased expression of SCARB1 mRNA
CTD
PMID:17299104
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Acvr2b
activin A receptor type 2B
increases expression
ISO
retinol acetate results in increased expression of ACVR2B mRNA
CTD
PMID:16772331
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression multiple interactions
ISO
retinol acetate results in decreased expression of ADIPOQ mRNA NR1I3 protein affects the reaction [retinol acetate results in decreased expression of ADIPOQ mRNA]
CTD
PMID:31449830
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Alb
albumin
affects binding
ISO
retinol acetate binds to ALB protein
CTD
PMID:17217919
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Apoe
apolipoprotein E
increases expression
ISO
retinol acetate results in increased expression of APOE mRNA
CTD
PMID:16772331
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Bcar1
BCAR1 scaffold protein, Cas family member
increases expression
ISO
retinol acetate results in increased expression of BCAR1 mRNA
CTD
PMID:16772331
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
G
Bmp4
bone morphogenetic protein 4
increases expression
ISO
retinol acetate results in increased expression of BMP4 mRNA
CTD
PMID:16772331
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bmp7
bone morphogenetic protein 7
increases expression
ISO
retinol acetate results in increased expression of BMP7 mRNA
CTD
PMID:16772331
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
G
Calm1
calmodulin 1
increases expression
ISO
retinol acetate results in increased expression of CALM1 mRNA
CTD
PMID:16772331
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Cbl
Cbl proto-oncogene
increases expression
ISO
retinol acetate results in increased expression of CBL mRNA
CTD
PMID:16772331
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Ccnb2
cyclin B2
increases expression
ISO
retinol acetate results in increased expression of CCNB2 mRNA
CTD
PMID:16772331
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
increases expression
ISO
retinol acetate results in increased expression of CCND1 mRNA
CTD
PMID:16772331
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
increases expression
ISO
retinol acetate results in increased expression of CCNE1 mRNA
CTD
PMID:16772331
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cd36
CD36 molecule
decreases expression multiple interactions
ISO
retinol acetate results in decreased expression of CD36 mRNA NR1I3 protein affects the reaction [retinol acetate results in decreased expression of CD36 mRNA]
CTD
PMID:31449830
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdx2
caudal type homeo box 2
increases expression
ISO
retinol acetate results in increased expression of CDX2 mRNA
CTD
PMID:16772331
NCBI chr12:7,726,798...7,733,142
Ensembl chr12:7,726,798...7,733,142
G
Cks2
CDC28 protein kinase regulatory subunit 2
increases expression
ISO
retinol acetate results in increased expression of CKS2 mRNA
CTD
PMID:16772331
NCBI chr17:13,570,611...13,575,770
G
Crk
CRK proto-oncogene, adaptor protein
increases expression
ISO
retinol acetate results in increased expression of CRK mRNA
CTD
PMID:16772331
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
G
Csnk2a1
casein kinase 2 alpha 1
increases expression
ISO
retinol acetate results in increased expression of CSNK2A1 mRNA
CTD
PMID:16772331
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
G
Ctsb
cathepsin B
increases expression
ISO
retinol acetate results in increased expression of CTSB mRNA
CTD
PMID:16772331
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsd
cathepsin D
increases expression
ISO
retinol acetate results in increased expression of CTSD mRNA
CTD
PMID:16772331
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
ISO
retinol acetate results in decreased expression of CYP1A1 mRNA
CTD
PMID:28123100
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of CYP26A1 mRNA; [retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of CYP26A1 protein; BMS453 inhibits the reaction [retinol acetate results in increased expression of CYP26A1 mRNA]; NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of CYP26A1 mRNA]; NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of CYP26A1 protein]; NR1I3 protein affects the reaction [retinol acetate results in increased expression of CYP26A1 mRNA]
CTD
PMID:16322074 PMID:31449830
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions decreases expression
ISO
[bisphenol A co-treated with retinol acetate] results in increased expression of CYP2B10 mRNA retinol acetate results in decreased expression of CYP2B10 mRNA
CTD
PMID:28123100
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
[LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of CYP2E1 mRNA
CTD
PMID:28123100
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dcn
decorin
increases expression
ISO
retinol acetate results in increased expression of DCN mRNA
CTD
PMID:16772331
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Dlx3
distal-less homeobox 3
increases expression
ISO
retinol acetate results in increased expression of DLX3 mRNA
CTD
PMID:16772331
NCBI chr10:80,064,489...80,069,891
Ensembl chr10:80,064,489...80,069,872
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
increases expression
ISO
retinol acetate results in increased expression of DNAJC3 mRNA
CTD
PMID:16772331
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
G
E2f3
E2F transcription factor 3
increases expression
ISO
retinol acetate results in increased expression of E2F3 mRNA
CTD
PMID:16772331
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
G
Ei24
EI24, autophagy associated transmembrane protein
increases expression
ISO
retinol acetate results in increased expression of EI24 mRNA
CTD
PMID:16772331
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
G
Eng
endoglin
increases expression
ISO
retinol acetate results in increased expression of ENG mRNA
CTD
PMID:16772331
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Ets2
ETS proto-oncogene 2, transcription factor
increases expression
ISO
retinol acetate results in increased expression of ETS2 mRNA
CTD
PMID:16772331
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Eya2
EYA transcriptional coactivator and phosphatase 2
increases expression
ISO
retinol acetate results in increased expression of EYA2 mRNA
CTD
PMID:16772331
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
G
Fgfr3
fibroblast growth factor receptor 3
increases expression
ISO
retinol acetate results in increased expression of FGFR3 mRNA
CTD
PMID:16772331
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
multiple interactions decreases expression
ISO
[bisphenol A co-treated with retinol acetate] results in decreased expression of FMO3 mRNA retinol acetate results in decreased expression of FMO3 mRNA
CTD
PMID:28123100
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Foxg1
forkhead box G1
increases expression
ISO
retinol acetate results in increased expression of FOXG1 mRNA
CTD
PMID:16772331
NCBI chr 6:66,674,797...66,677,611
Ensembl chr 6:66,666,587...66,678,607
G
Frzb
frizzled-related protein
increases expression
ISO
retinol acetate results in increased expression of FRZB mRNA
CTD
PMID:16772331
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Fxn
frataxin
increases expression
ISO
retinol acetate results in increased expression of FXN mRNA
CTD
PMID:16772331
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
G
Fzd3
frizzled class receptor 3
increases expression
ISO
retinol acetate results in increased expression of FZD3 mRNA
CTD
PMID:16772331
NCBI chr15:39,421,366...39,488,369
Ensembl chr15:39,421,355...39,488,369
G
Fzd6
frizzled class receptor 6
increases expression
ISO
retinol acetate results in increased expression of FZD6 mRNA
CTD
PMID:16772331
NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
retinol acetate results in increased expression of GADD45A mRNA
CTD
PMID:16772331
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
retinol acetate results in increased expression of GAPDH mRNA
CTD
PMID:16772331
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
retinol acetate results in increased expression of HES1 mRNA
CTD
PMID:16772331
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
ISO
retinol acetate results in increased expression of HPRT1 mRNA
CTD
PMID:16772331
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hspa4l
heat shock protein family A (Hsp70) member 4 like
increases expression
ISO
retinol acetate results in increased expression of HSPA4L mRNA
CTD
PMID:16772331
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
retinol acetate results in increased expression of HSPH1 mRNA
CTD
PMID:16772331
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
retinol acetate results in increased expression of ID3 mRNA
CTD
PMID:16772331
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Il4
interleukin 4
increases expression
ISO
retinol acetate results in increased expression of IL4 protein
CTD
PMID:11444878
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
affects response to substance increases expression
ISO
IL5 protein affects the susceptibility to retinol acetate retinol acetate results in increased expression of IL5 protein
CTD
PMID:11444878
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il5ra
interleukin 5 receptor subunit alpha
affects response to substance
ISO
IL5RA protein affects the susceptibility to retinol acetate
CTD
PMID:11444878
NCBI chr 4:139,630,652...139,664,593
Ensembl chr 4:139,632,066...139,668,544
G
Il6
interleukin 6
increases expression
ISO
retinol acetate results in increased expression of IL6 protein
CTD
PMID:11444878
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
retinol acetate results in increased expression of JUND mRNA
CTD
PMID:16772331
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kif1b
kinesin family member 1B
increases expression
ISO
retinol acetate results in increased expression of KIF1B mRNA
CTD
PMID:16772331
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
G
Kl
Klotho
increases expression
ISO
retinol acetate results in increased expression of KL mRNA
CTD
PMID:16772331
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Lama5
laminin subunit alpha 5
increases expression
ISO
retinol acetate results in increased expression of LAMA5 mRNA
CTD
PMID:16772331
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
G
Laptm4a
lysosomal protein transmembrane 4 alpha
increases expression
ISO
retinol acetate results in increased expression of LAPTM4A mRNA
CTD
PMID:16772331
NCBI chr 6:31,719,287...31,737,023
Ensembl chr 6:31,718,976...31,737,020
G
Lifr
LIF receptor subunit alpha
increases expression
ISO
retinol acetate results in increased expression of LIFR mRNA
CTD
PMID:16772331
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Lrat
lecithin retinol acyltransferase
multiple interactions
ISO
[LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in decreased expression of CYP2C39 mRNA; [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of CYP2E1 mRNA; [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of CYP4A10 mRNA; [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of MGST1 mRNA; [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of UGT1A1 mRNA; retinol acetate inhibits the reaction [LRAT gene mutant form results in decreased susceptibility to Thioacetamide]
CTD
PMID:24614237 PMID:28123100
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Ltbr
lymphotoxin beta receptor
increases expression
ISO
retinol acetate results in increased expression of LTBR mRNA
CTD
PMID:16772331
NCBI chr 4:158,108,884...158,115,339
Ensembl chr 4:158,108,886...158,121,539
G
Map3k3
mitogen activated protein kinase kinase kinase 3
increases expression
ISO
retinol acetate results in increased expression of MAP3K3 mRNA
CTD
PMID:16772331
NCBI chr10:91,020,174...91,088,852
Ensembl chr10:91,020,174...91,088,848
G
Mapk14
mitogen activated protein kinase 14
increases expression
ISO
retinol acetate results in increased expression of MAPK14 mRNA
CTD
PMID:16772331
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapkapk2
MAPK activated protein kinase 2
increases expression
ISO
retinol acetate results in increased expression of MAPKAPK2 mRNA
CTD
PMID:16772331
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
retinol acetate results in increased expression of MET mRNA
CTD
PMID:16772331
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mgst1
microsomal glutathione S-transferase 1
increases expression multiple interactions
ISO
retinol acetate results in increased expression of MGST1 mRNA [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of MGST1 mRNA
CTD
PMID:28123100
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mmp2
matrix metallopeptidase 2
increases expression
ISO
retinol acetate results in increased expression of MMP2 mRNA
CTD
PMID:16772331
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Msx1
msh homeobox 1
increases expression
ISO
retinol acetate results in increased expression of MSX1 mRNA
CTD
PMID:16772331
NCBI chr14:72,961,036...72,964,970
Ensembl chr14:72,961,148...72,964,966
G
Msx2
msh homeobox 2
increases expression
ISO
retinol acetate results in increased expression of MSX2 mRNA
CTD
PMID:16772331
NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,097,103...11,102,879
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
increases expression
ISO
retinol acetate results in increased expression of MYCN mRNA
CTD
PMID:16772331
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Myo1b
myosin Ib
increases expression
ISO
retinol acetate results in increased expression of MYO1B mRNA
CTD
PMID:16772331
NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798
G
Nfkbia
NFKB inhibitor alpha
increases expression
ISO
retinol acetate results in increased expression of NFKBIA mRNA
CTD
PMID:16772331
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nid1
nidogen 1
increases expression
ISO
retinol acetate results in increased expression of NID1 mRNA
CTD
PMID:16772331
NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267
G
Notch1
notch receptor 1
increases expression
ISO
retinol acetate results in increased expression of NOTCH1 mRNA
CTD
PMID:16772331
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Notch2
notch receptor 2
increases expression
ISO
retinol acetate results in increased expression of NOTCH2 mRNA
CTD
PMID:16772331
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of CYP26A1 mRNA]; NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of CYP26A1 protein]; NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA]; NR1I3 protein affects the reaction [retinol acetate results in decreased expression of ADIPOQ mRNA]; NR1I3 protein affects the reaction [retinol acetate results in decreased expression of CD36 mRNA]; NR1I3 protein affects the reaction [retinol acetate results in increased expression of CYP26A1 mRNA]
CTD
PMID:31449830
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
ISO
retinol acetate results in increased expression of PEA15A mRNA
CTD
PMID:16772331
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
ISO
retinol acetate results in increased expression of PHGDH mRNA
CTD
PMID:16772331
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
retinol acetate results in increased expression of PIK3R1 mRNA
CTD
PMID:16772331
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA; NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA]
CTD
PMID:31449830
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Psen2
presenilin 2
increases expression
ISO
retinol acetate results in increased expression of PSEN2 mRNA
CTD
PMID:16772331
NCBI chr13:91,967,506...91,993,240
Ensembl chr13:91,967,983...91,993,174
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
increases expression
ISO
retinol acetate results in increased expression of PTPN13 mRNA
CTD
PMID:16772331
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Rad50
RAD50 double strand break repair protein
increases expression
ISO
retinol acetate results in increased expression of RAD50 mRNA
CTD
PMID:16772331
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rangap1
RAN GTPase activating protein 1
increases expression
ISO
retinol acetate results in increased expression of RANGAP1 mRNA
CTD
PMID:16772331
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
G
Rbp4
retinol binding protein 4
increases expression
ISO
retinol acetate results in increased expression of RBP4 protein
CTD
PMID:31449830
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Ror1
receptor tyrosine kinase-like orphan receptor 1
increases expression
ISO
retinol acetate results in increased expression of ROR1 mRNA
CTD
PMID:16772331
NCBI chr 5:114,744,311...115,088,155
Ensembl chr 5:114,744,304...115,088,155
G
Rxra
retinoid X receptor alpha
increases expression
ISO
retinol acetate results in increased expression of RXRA mRNA
CTD
PMID:16772331
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Satb1
SATB homeobox 1
increases expression
ISO
retinol acetate results in increased expression of SATB1 mRNA
CTD
PMID:16772331
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Sdc1
syndecan 1
increases expression
ISO
retinol acetate results in increased expression of SDC1 mRNA
CTD
PMID:16772331
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Sim2
SIM bHLH transcription factor 2
increases expression
ISO
retinol acetate results in increased expression of SIM2 mRNA
CTD
PMID:16772331
NCBI chr11:33,414,218...33,453,663
Ensembl chr11:33,414,218...33,453,663
G
Smn1
survival of motor neuron 1, telomeric
increases expression
ISO
retinol acetate results in increased expression of SMN1 mRNA
CTD
PMID:16772331
NCBI chr 2:31,490,018...31,501,065
Ensembl chr 2:31,490,015...31,501,060
G
Snai1
snail family transcriptional repressor 1
increases expression
ISO
retinol acetate results in increased expression of SNAI1 mRNA
CTD
PMID:16772331
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
retinol acetate results in increased expression of SNAI2 mRNA
CTD
PMID:16772331
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Sqstm1
sequestosome 1
increases expression
ISO
retinol acetate results in increased expression of SQSTM1 mRNA
CTD
PMID:16772331
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Tbx2
T-box transcription factor 2
increases expression
ISO
retinol acetate results in increased expression of TBX2 mRNA
CTD
PMID:16772331
NCBI chr10:70,679,670...70,688,868
Ensembl chr10:70,679,518...70,688,529
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
retinol acetate results in increased expression of TIMP3 mRNA
CTD
PMID:16772331
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tyro3
TYRO3 protein tyrosine kinase
increases expression
ISO
retinol acetate results in increased expression of TYRO3 mRNA
CTD
PMID:16772331
NCBI chr 3:106,777,686...106,797,154
Ensembl chr 3:106,777,635...106,797,142
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
ISO
[LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in increased expression of UGT1A1 mRNA
CTD
PMID:28123100
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Wnt11
Wnt family member 11
increases expression
ISO
retinol acetate results in increased expression of WNT11 mRNA
CTD
PMID:16772331
NCBI chr 1:153,134,503...153,154,294
Ensembl chr 1:153,138,197...153,154,294
G
Wnt7b
Wnt family member 7B
increases expression
ISO
retinol acetate results in increased expression of WNT7B mRNA
CTD
PMID:16772331
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
increases expression
ISO
retinol acetate results in increased expression of YWHAZ mRNA
CTD
PMID:16772331
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all